ÌÇÐÄvlog´«Ã½

Europe Electrophysiology Market Analysis

The Europe Electrophysiology Market size is estimated at USD 2.53 billion in 2024, and is expected to reach USD 4.07 billion by 2029, growing at a CAGR of 10.02% during the forecast period (2024-2029).

The COVID-19 pandemic is expected to have a notable impact on the Europe Electrophysiology Market, as most of the surgeries and non-urgent procedures were deferred to reserve the hospital infrastructure for the treatment of COVID-19 patients. According to the research article published in European Heart Journal, 2020, Atrial fibrillation is characterized by the presence of elevated levels of biomarkers for systemic inflammation, and a close relation was observed between the inflammation of epicardial fat and the severity of electrical abnormalities in the adjacent atrial myocardium. In this context, patients with Atrial fibrillation can exhibit a worsened outcome on infection with the SARS-CoV2 virus. Additionally, as per the research article published in the Journal of Cardiovascular Pharmacology, 2020, the pharmacokinetic interactions between the drugs used in the treatment of atrial fibrillation and the experimental therapies used in the treatment of COVID-19, had resulted in limited handling in clinical practice, as these drug interactions are expected to cause electrocardiographic abnormalities such as extreme bradycardia, and QRS widening, and thus careful electrocardiographic monitoring is required during the concomitant administration. Thus, owing to the aforementioned factors, the studied market is expected to be impacted during the COVID-19 pandemic.

Certain factors that are driving the growth of the market include the increasing prevalence of target diseases, technological advancements in the field of electrophysiology, and increasing demand for catheter ablation procedures. According to the European Society of Cardiology, 2019 statistics, more than 6 million cases of cardiovascular diseases (CVDs) were diagnosed in European Union and nearly 11 million CVD cases were reported in total Europe every year. Additionally, CVDs are responsible for nearly 3.9 million deaths in Europe annually. Since electrophysiology devices have their major applications in detecting heart failure rates, the increasing number of cardiovascular diseases is expected to drive the market during the forecast period.

However, according to the European Union of Medical Specialists, very few cardiologists hold a specialization in electrophysiology. Although not a favorable percentage, the electrophysiology workforce is more or less stable in Europe. Still, due to lack of mobility among the majority of the established electrophysiologists, there exists a distinct lag in geographical dispersion of the EPs, which resulted in a rift between the demand and supply, and a visible disparity among electrophysiologists. Thus, the lack of skilled electrophysiologists is acting as a major restraint for the growth of the European electrophysiology market.

Europe Electrophysiology Market Trends

This section covers the major market trends shaping the Europe Electrophysiology Market according to our research experts:

Ablation Catheters is Expected to Hold the Largest Market Share in the Product Segment Over the Forecast Period in European Market

Europe Electrophysiology Industry Segmentation

Electrophysiology is the biomedical field that deals with the study of electric activity in the body. Electrophysiology includes the study of the generation of electrical activity and the effects of that electrical activity on the body. As per the scope of this report, the various types of electrophysiology products and the diseases that they target have been taken into account for the calculation of the total market size in Europe. The Europe Electrophysiology Market is segmented by Product, Disease, and Geography. By Product, the market is segmented into Ablation Catheters, Laboratory Devices, Diagnostic Catheters, Access Devices, and Other Products. By Disease, the market is segmented into Atrial Fibrillation, Atrial Flutter, Wolff-Parkinson-White Syndrome, Atrioventricular Nodal Reentry Tachycardia, and Other Target Diseases. By Geography, the market is segmented into United Kingdom, Germany, France, Italy, Spain, and Rest of Europe. The report offers the value (in USD million) for the above segments.